Found: 14
Select item for more details and to access through your institution.
Role of calcium dysregulation in Alzheimer's disease and its therapeutic implications.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 453, doi. 10.1111/cbdd.14175
- By:
- Publication type:
- Article
Cyanidin as potential anticancer agent targeting various proliferative pathways.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 438, doi. 10.1111/cbdd.14173
- By:
- Publication type:
- Article
Development and radiosterilization of new hydrazono‐quinoline hybrids as DNA gyrase and topoisomerase IV inhibitors: Antimicrobial and hemolytic activities against uropathogenic isolates with molecular docking study.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 245, doi. 10.1111/cbdd.14154
- By:
- Publication type:
- Article
A 9‐gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co‐expression and regression analyses.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 422, doi. 10.1111/cbdd.14141
- By:
- Publication type:
- Article
Design, synthesis, and biological evaluation of novel NO‐releasing 4‐chromanone derivatives as potential vasodilator agents.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 408, doi. 10.1111/cbdd.14140
- By:
- Publication type:
- Article
Classification analysis of fatty acid synthase inhibitors using multialgorithms on topological descriptors and structural fingerprints.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 395, doi. 10.1111/cbdd.14138
- By:
- Publication type:
- Article
Computational prediction of Lee retention indices of polycyclic aromatic hydrocarbons by using machine learning.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 380, doi. 10.1111/cbdd.14137
- By:
- Publication type:
- Article
Design, synthesis, and biological evaluation of tetrahydroisoquinoline stilbene derivatives as potential antitumor candidates.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 364, doi. 10.1111/cbdd.14134
- By:
- Publication type:
- Article
Anti‐Candida, docking studies, and in vitro metabolism‐mediated cytotoxicity evaluation of Eugenol derivatives.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 350, doi. 10.1111/cbdd.14131
- By:
- Publication type:
- Article
C2‐linked alkynyl poly‐ethylene glycol(PEG) adenosine conjugates as water‐soluble adenosine receptor agonists.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 340, doi. 10.1111/cbdd.14128
- By:
- Publication type:
- Article
Novel hybrid virtual screening protocol based on pharmacophore and molecular docking for discovery of GSK‐3β inhibitors.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 326, doi. 10.1111/cbdd.14111
- By:
- Publication type:
- Article
Promising anticonvulsant and/or analgesic compounds among 5‐chloro‐2‐ or 5‐chloro‐4‐methyl derivatives of xanthone coupled to aminoalkanol moieties—Design, synthesis and pharmacological evaluation.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 278, doi. 10.1111/cbdd.14102
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. i, doi. 10.1111/cbdd.14070
- Publication type:
- Article
Discovery of novel 1,3,5‐triazines as potent antibacterial agent against urinary tract infection‐causing clinical isolates of Escherichia coli via inhibition of DNA Gyrase.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 2, p. 271, doi. 10.1111/cbdd.14066
- By:
- Publication type:
- Article